# DMD Therapeutics Inc. — Form D

DMD Therapeutics Inc. of Seattle, WA, a company, filed a Form D exempt-offering notice with the SEC on 2016-08-11. The offering totals $600K. Industry: Other.

## Offering

- Filed: 2016-08-11
- Form: D
- Accession: 0001681820-16-000002
- Industry: Other
- Exemptions: 06b
- Total offering: $600K
- Remaining: $600K
- Minimum investment: $100K
- Investors: 3
- Date of first sale: 2016-07-26
- Revenue range: Decline to Disclose
- SEC file number: 021-268698

## Issuer

- Name: DMD Therapeutics Inc.
- CIK: 0001681820
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2015
- Address: 2032 41st Avenue E, Seattle, WA, 98112
- Phone: 2067901094

## Officers, directors & promoters (3)

| Name | Role | Location |
| --- | --- | --- |
| Ronald Berenson | Director | Seattle, WA |
| Ronald Berenson | Executive Officer | Seattle, WA |
| Ronald Berenson | Promoter | Seattle, WA |

## More

- [CIK 1681820 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1681820&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001681820-16-000002.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.